Selina Koch
Executive Editor at BioCentury who conducts interviews on neuroscience and psychiatry drug development and summarizes insights from conversations with industry leaders.
Best podcasts with Selina Koch
Ranked by the Snipd community
25 snips
Feb 10, 2026 • 34min
Ep. 349 - Start-up Spotlight, Compounding Wegovy & Neuropysch
Selina Koch, neuroscience and psychiatry editor who interviews industry leaders. Steve Usdin, policy analyst focused on FDA and biomedical funding. Danielle Golovin, analyst tracking Series A and VC trends. They discuss 2025 Series A stabilization and which modalities drew funding. They debate how compounded Wegovy affects innovation and cover Congress defending NIH budgets. They explore serendipity versus engineering in psychiatric drug discovery.
Sep 7, 2024 • 32min
Ep. 251 - Eyes on the target: a Back to School Overview
Simone Fishburn, Editor in Chief of BioCentury, Selina Koch, Executive Editor, and Lauren Martz, Executive Director of Biopharma Intelligence, discuss major trends in biopharma. They highlight the shift towards human-first, causal biology aimed at improving drug translation. Key topics include immunoproteomics outpacing genomics in inflammation and immunology target discovery. The trio also explores advancements in neuroscience, emphasizing how precision medicine can validate targets using biomarkers, ultimately reshaping clinical approaches in drug development.
